AKT1 and neoplasm: In corroboration with these findings, the suppression of TRAF6 by shRNA impairs Akt activation in prostate cancer cells, suppresses tumor formation in the xenograft tumor model and potentiates apoptosis induced by chemotherapy agents [54].